SCHEMBL7860583

SCHEMBL7860583

COc1ccc(-c2nn(-c3ccccc3)cc2C)cc1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.58
ALDH1A1 P00352 3/20 0.58
HPGD P15428 2/20 0.58
HSD17B10 Q99714 2/20 0.58
KMT2A Q03164 7/20 0.56
MEN1 O00255 6/20 0.55
MAPT P10636 6/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
POLB P06746 2/20 0.51
MAPK1 P28482 2/20 0.51
TSHR P16473 2/20 0.51
MITF O75030 1/20 0.51
RAB9A P51151 3/20 0.49
NPC1 O15118 2/20 0.49
LMNA P02545 3/20 0.48
ALOX12 P18054 1/20 0.48
HTT P42858 2/20 0.47
GAA P10253 1/20 0.47
ATM Q13315 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7859639 0.81 MEN1 (0.72) KDM4EALDH1A1KMT2AMEN1MAPT
SCHEMBL7852486 0.78 PTGS2 (0.57) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL16911530 0.78 SRC (0.44) KDM4EALDH1A1MAPTPOLBMAPK1
SCHEMBL7859556 0.77 KMT2A (0.49) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL7852489 0.75 CNR1 (0.60) KDM4EALDH1A1HPGDKMT2AMEN1
SCHEMBL8373366 0.75 MEN1 (0.55) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL6682820 0.74 HPGD (1.00) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL11255270 0.74 KMT2A (0.73) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL11240462 0.74 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL29644376 0.71 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947717-B2 Inhibitors of lethal factor protease BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-05-24 US disclosed
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE THE BURNHAM INSTITUTE (US) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE APAF1, F11, SERPINB1 KDM4E 2404/4885ALDH1A1 4227/4885HPGD 1710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.